NM_001849.4:c.2611G>A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PP3_ModeratePP5_Very_Strong
The NM_001849.4(COL6A2):c.2611G>A(p.Asp871Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000138 in 1,592,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. D871D) has been classified as Likely benign.
Frequency
Consequence
NM_001849.4 missense
Scores
Clinical Significance
Conservation
Publications
- collagen 6-related myopathyInheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
- Ullrich congenital muscular dystrophy 1BInheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
- Bethlem myopathy 1AInheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
- Ullrich congenital muscular dystrophy 1AInheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myosclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL6A2 | NM_001849.4 | c.2611G>A | p.Asp871Asn | missense_variant | Exon 28 of 28 | ENST00000300527.9 | NP_001840.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152174Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.00000973 AC: 2AN: 205616 AF XY: 0.0000177 show subpopulations
GnomAD4 exome AF: 0.0000139 AC: 20AN: 1440692Hom.: 0 Cov.: 33 AF XY: 0.0000140 AC XY: 10AN XY: 715984 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152174Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74342 show subpopulations
ClinVar
Submissions by phenotype
Bethlem myopathy 1A Pathogenic:2
Criteria applied: PM3_STR,PM2_SUP_MOD,PS3_SUP -
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 871 of the COL6A2 protein (p.Asp871Asn). This variant is present in population databases (rs387906610, gnomAD 0.006%). This missense change has been observed in individual(s) with autosomal recessive Bethlem myopathy and/or Ullrich congenital muscular dystrophy (PMID: 19949035, 25533456, 29419890). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 29644). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL6A2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects COL6A2 function (PMID: 19949035, 25533456). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
- -
- -
Collagen 6-related myopathy Pathogenic:1
The COL6A2 c.2611G>A (p.Asp871Asn) missense variant has been reported three studies and is found in a total of three individuals with collagen type VI-related disorders, including one in a homozygous state and two in a compound heterozygous state (Gualandi et al., 2009; Zamurs et al., 2015; Fan et al. 2018). The homozygote and one compound heterozygote exhibited Bethlem myopathy and the second compound heterozygote exhibited Ullrich congenital muscular dystrophy. The p.Asp871Asn variant was absent from 100 control subjects and is reported at a frequency of 0.000013 in the Total population of the Genome Aggregation Database. Functional studies conducted using proband fibroblasts and mammalian cells indicated that the p.Asp871Asn variant severely reduced collagen VI synthesis, assembly, and secretion (Gualandi et al., 2009; Zamurs et al., 2015). Based on the evidence, the p.Asp871Asn variant is classified as likely pathogenic for collagen type VI-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
BETHLEM MYOPATHY 1B, AUTOSOMAL RECESSIVE Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at